China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

The TB-CHAMP (Tuberculosis Child Multidrug-Resistant Preventive Therapy) trial was designed to assess the efficacy and safety of levofloxacin as compared with placebo as tuberculosis preventive ...

(Yicai) Jan. 3 -- US pharmaceutical company Gilead Sciences has been given the greenlight by Chinese regulators to sell its ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken ...